Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-9 of 9 for your search:
Cancer Type:
Skin cancer, nonmelanomatous (squamous and basal cell)
Stage/Subtype of Cancer:
basal cell carcinoma of the skin
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
A Phase II Single Arm Open-Label Clinical Trial of Chemotherapy of BCCs With Tazarotene 0.1% in Subjects With Basal Cell Nevus Syndrome
Phase:
Phase II, Phase I
Type:
Prevention, Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
2007-018
, NCT00500643
2.
Phase II Study of Aminolevulinic Acid and Photodynamic Therapy in Patients With Cutaneous Carcinomas or Actinic Keratosis
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
NCI
Protocol IDs:
RPCI-DS-96-55
, NCI-G97-1224, NCT00002975
3.
To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
PEP005-009
, NCT00432185
4.
Phase II Study of Topical Tazarotene in Patients With Basal Cell Nevus Syndrome and Basal Cell Carcinoma on the Face
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 to 75
Sponsor:
NCI
Protocol IDs:
CHORI-2007-016
, UCSF-05862, R01-CA-109584, NCT00489086, 05862
5.
Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CTL0108
, NCT00604890
6.
Phase II Study of Intralesional Photodynamic Therapy Using Aminolevulinic Acid and Non-Coherent Blue Light in Patients With Basal Cell Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
30 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
DUSA-PDT-BCC-06
, DUSA-PDT-BCC-06, NCT00747903
7.
Phase II Randomized Study of Tazarotene Applied to Patients with Basal Cell Carcinoma and Basal Cell Nevus Syndrome on the Chest and Back
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 - 75
Sponsor:
NCI
Protocol IDs:
CHORI-2007-022
, 05862, CHORI-H473-26042, NCT00783965
8.
A Study Evaluating the Efficacy and Safety of GDC-0449 (Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
SHH4476g
, NCT00833417
9.
Effect of the Subconscious on Mohs Micrographic Surgery
Phase:
No phase specified
Type:
Supportive care, Treatment
Status:
Active
Age:
25 and over
Sponsor:
Other
Protocol IDs:
1253-017
, NCT00374062
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute